LysaKare

· Advanced Accelerator Applications

Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for LysaKare, covering 2025-01-24 to 2026-07-21. Get the full timeline:

Most recent: EMA Authorised: LysaKare (L-arginine hydrochloride;L-lysine hydrochloride) — Novartis Europharm Limited